Willam N Kelley Net Worth

The estimated Net Worth of Willam N Kelley is at least $17.4 Thousand dollars as of 8 August 2017. Willam Kelley owns over 30,000 units of Asensus Surgical Inc stock worth over $17,395 and over the last 15 years Willam sold ASXC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Willam Kelley ASXC stock SEC Form 4 insiders trading

Willam has made over 2 trades of the Asensus Surgical Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Willam bought 30,000 units of ASXC stock worth $21,300 on 8 August 2017.

The largest trade Willam's ever made was buying 30,000 units of Asensus Surgical Inc stock on 8 August 2017 worth over $21,300. On average, Willam trades about 2,273 units every 29 days since 2009. As of 8 August 2017 Willam still owns at least 50,000 units of Asensus Surgical Inc stock.

You can see the complete history of Willam Kelley stock trades at the bottom of the page.

Insiders trading at Asensus Surgical Inc

Over the last 11 years, insiders at Asensus Surgical Inc have traded over $32,677,440 worth of Asensus Surgical Inc stock and bought 7,457,173 units worth $15,992,743 . The most active insiders traders include Jane Ph D Hsiao, Anthony C. J. Fernando, and William N Jr Starling. On average, Asensus Surgical Inc executives and independent directors trade stock every 46 days with the average trade being worth of $97,582. The most recent stock trade was executed by Rampertab Shameze on 21 April 2024, trading 81,521 units of ASXC stock currently worth $28,361.

What does Asensus Surgical Inc do?

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.

Complete history of Willam Kelley stock trades at Merck & Co Inc and Asensus Surgical Inc

Asensus Surgical Inc executives and stock owners

Asensus Surgical Inc executives and other stock owners filed with the SEC include:

• Anthony Fernando,
  President, Chief Executive Officer, Director
• Anthony Fernando,
  Pres, CEO & Director
• Shameze Rampertab B.Sc. MBA, CA, CPA,
  Exec. VP & CFO
• Paul LaViolette,
  Independent Chairman of the Board
• Richard Pfenniger,
  Independent Director
• David Milne,
  Independent Director
• William Starling,
  Independent Director
• William Kelley,
  Independent Director
• Jane Hsiao,
  Independent Director
• Andrea Biffi,
  Independent Director
• Shameze Rampertab,
  Chief Financial Officer, Executive Vice President
• Dr. Stephanie M. Fitts,
  VP of Clinical, Quality and Regulatory Affairs
• Amanda Owens,
  Global Head of People
• Paul Ziegler Jr.,
  VP of Sales
• Joshua B. Weingard,
  Chief Legal Officer & Sec.
• Eric A Smith,
  Chief Commercial Officer
• Joseph P Slattery,
  EVP and CFO
• Aftab Kherani,
  Director
• Willam N Kelley,
  Director
• Todd Pope,
  President and CEO
• S.P.A Sofar,,
  10% owner
• Brett Farabaugh,
  Interim CFO
• Capital Iii Lp Aisling Capi...,
  
• Iv, Llcsv Life Sciences Fun...,
  
• Dennis Dougherty,
  Director
• Richard Mueller,
  Chief Operating Officer
• Kevin J Hobert,
  Director
• Elizabeth Kwo,
  Director